MII NS Studie EudraCT - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

NamingSystem: MII NS Studie EudraCT

Official URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/NamingSystem/mii-ns-studie-eudract				Version: 2027.0.0-ballot.1
Active as of 2024-07-19				Computable Name: MII_NS_Studie_EudraCT

NamingSystem für Identifikatoren der European Union Drug Regulating Authorities Clinical Trials (EudraCT)

Language: en

Summary

Defining URL

https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/NamingSystem/mii-ns-studie-eudract

Version

2027.0.0-ballot.1

Name

MII_NS_Studie_EudraCT

Status

active

Definition

NamingSystem für Identifikatoren der European Union Drug Regulating Authorities Clinical Trials (EudraCT)

Publisher

Medizininformatik-Initiative

Identifiers

Type

Value

Preferred

URI

https://www.medizininformatik-initiative.de/fhir/modul-studie/sid/eudract

true

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-15
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.